BEOVU
LIVE

Serial Number

79226907

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

BEOVU Trademark

Serial Number: 79226907 • Registration: 5494796

BEOVU is a trademark filed by NOVARTIS AG on November 6, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 6, 2017

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; ] pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; [ pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for ophthalmological use [ ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 16, 2026 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 10, 2026 INPS
INVALIDATION PROCESSED
Feb 10, 2026 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 17, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 17, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Dec 17, 2024 71AG
TEAS SECTION 15 RECEIVED
Nov 13, 2024 E15R
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 13, 2024 APRE
TEAS SECTION 71 RECEIVED
Mar 21, 2024 ES71
NOTIFICATION PROCESSED BY IB
Aug 3, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 19, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 19, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 19, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTICE OF PUBLICATION
Mar 14, 2018 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 2, 2018 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2018 CNSA
ASSIGNED TO EXAMINER
Feb 26, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 16, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR